Next Article in Journal
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
Next Article in Special Issue
Nanofibers in Ocular Drug Targeting and Tissue Engineering: Their Importance, Advantages, Advances, and Future Perspectives
Previous Article in Journal
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects
Previous Article in Special Issue
Management of Sjogren’s Dry Eye Disease—Advances in Ocular Drug Delivery Offering a New Hope
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(2), 550; https://doi.org/10.3390/pharmaceutics15020550
Action Date Notes Link
article xml file uploaded 7 February 2023 08:18 CET Original file -
article xml uploaded. 7 February 2023 08:18 CET Update https://www.mdpi.com/1999-4923/15/2/550/xml
article pdf uploaded. 7 February 2023 08:18 CET Version of Record https://www.mdpi.com/1999-4923/15/2/550/pdf
article html file updated 7 February 2023 08:19 CET Original file https://www.mdpi.com/1999-4923/15/2/550/html
Back to TopTop